RWMG
PRAX icon

Redwood Wealth Management Group’s Praxis Precision Medicines PRAX Stock Holding History

Redwood Wealth Management Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,105
Closed -$45.7K – 846
2024
Q2 		$45.7K Buy
+1,105
New +$52.2K 0.03% 321

Other funds holding PRAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Redwood Wealth Management Group's PRAX Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of Praxis Precision Medicines (PRAX) in Q3 2024, closing a stake of 1,105 shares — an estimated $45.7K sold.

Redwood Wealth Management Group first reported a position in PRAX in Q2 2024 and held it in 1 quarter. The position peaked at $45.7K in Q2 2024. 134 funds tracked by Wall St. Rank hold PRAX as of Q3 2024.

  • Redwood Wealth Management Group reported no remaining Praxis Precision Medicines position as of Q3 2024 after selling out during the quarter.
  • Redwood Wealth Management Group sold 1,105 Praxis Precision Medicines shares in Q3 2024, an estimated $45.7K.
  • Redwood Wealth Management Group first reported a position in Praxis Precision Medicines in Q2 2024 and held it in 1 quarter.
  • Redwood Wealth Management Group's Praxis Precision Medicines position peaked at $45.7K in Q2 2024.
  • 134 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.